It was reported that CXCR4 was expressed at higher levels in pancreatic cancer cells and could influence the clinical outcome of PDA patients (Wehler et al, 2006; Billadeau et al, 2006). The gene discussed is CXCR4; the disease is pancreatic neoplasm.